{
  "docId": "019de074-ddab-749d-b286-5e01e8bcb935",
  "docSlug": "f43e68719e672319f390e5844d5bc5fe",
  "documentTitle": "Chimerix | Investor Presentation Deck | 41 slides",
  "authorId": "chimerix",
  "authorName": "Chimerix",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-05-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 4,
  "pageCount": 41,
  "prevPage": 3,
  "nextPage": 5,
  "slideType": "roadmap",
  "function": "plan_implementation",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "The slide uses a Gantt-style chart to map drug candidates against development phases.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de074-ddab-749d-b286-5e01e8bcb935/4",
  "deckHref": "/decks/019de074-ddab-749d-b286-5e01e8bcb935",
  "deckJsonHref": "/decks/019de074-ddab-749d-b286-5e01e8bcb935.json",
  "deckAnchorHref": "/decks/019de074-ddab-749d-b286-5e01e8bcb935#slide-4",
  "components": [
    {
      "bbox": {
        "h": 0.055,
        "w": 0.301,
        "x": 0.104,
        "y": 0.925
      },
      "kind": "source-note",
      "text": "1. Malignant glioma 2. Adult recurrent H3 K27M-mutant high-grade glioma 3. H3 K27M-mutant glioma 4. Central Nervous System 5. Rapidly Emerging Antiviral Drug Development Initiative",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6569ba8d-8470-41e8-8d6a-7a1d1dff9b12",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.795,
        "w": 0.896,
        "x": 0.052,
        "y": 0.132
      },
      "kind": "table",
      "text": "Pipeline table showing drug candidates (ONC201, ONC206, ONC212, CMX521, TEMBEXA) across development stages (Preclinical, Phase 1, Phase 2, Registrational, Approved) and collaborators.",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "20536286-eb5c-43c2-ad06-e630197e2401",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.045,
        "w": 0.608,
        "x": 0.196,
        "y": 0.038
      },
      "kind": "title",
      "text": "Deep pipeline across all development stages",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "781b6f47-4ffd-4f2b-b550-6e49fc689959",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Table data",
      "slug": "table-data",
      "agent": null,
      "layer": "slide",
      "matchId": "d8b2cb38-3cbe-42fc-bfea-c3380c918c56",
      "evidence": "table/data: Pipeline table showing drug candidates (ONC201, ONC206, ONC212, CMX521, TEMBEXA) across development stages (Preclinical, Phase 1, Phase 2, Registrational, Approved) and collaborators.",
      "confidence": 0.7
    }
  ],
  "frameworks": [
    {
      "name": "gantt-chart",
      "slug": null,
      "matchId": "36237f08-fc15-4806-a546-b31b3226d204",
      "evidence": "The slide uses horizontal bars to represent the duration and status of drug development programs across a timeline of phases.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}